Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:12 pm Purchase |
2023-12-29 | 13G | Oncternal Therapeutics, Inc. ONCT |
The Vanguard Group | 2,860,906 4.850% |
2,860,906 (New Position) |
Filing History |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Oncternal Therapeutics, Inc. ONCT |
BLACKROCK INC BLK |
50,277 2.000% |
-109,600 (-68.55%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Oncternal Therapeutics, Inc. ONCT |
BLACKROCK INC BLK |
159,877 6.500% |
159,877 (New Position) |
Filing History |
| 2021-02-16 5:04 pm Sale |
2020-12-31 | 13G | Oncternal Therapeutics, Inc. ONCT |
Armistice Capital, LLC | 64,047 3.000% |
-14,777 (-18.75%) |
Filing History |
| 2021-02-16 09:48 am Sale |
2020-12-31 | 13G | Oncternal Therapeutics, Inc. ONCT |
CVI Investments, Inc. | 0 0.000% |
-125,000 (Position Closed) |
Filing History |
| 2020-12-18 4:05 pm Purchase |
2020-12-18 | 13D | Oncternal Therapeutics, Inc. ONCT |
HYDE JOSEPH R III | 73,407 2.990% |
1,904 (+2.66%) |
Filing History |
| 2020-12-18 12:06 pm Purchase |
2020-12-09 | 13G | Oncternal Therapeutics, Inc. ONCT |
CVI Investments, Inc. | 125,000 6.400% |
125,000 (New Position) |
Filing History |
| 2020-07-23 4:36 pm Purchase |
2020-07-17 | 13D | Oncternal Therapeutics, Inc. ONCT |
Shanghai Pharmaceuticals (HK) Investment Ltd | 203,454 19.900% |
203,454 (New Position) |
Filing History |
| 2020-05-29 5:06 pm Purchase |
2020-05-19 | 13G | Oncternal Therapeutics, Inc. ONCT |
Armistice Capital, LLC | 78,824 9.100% |
78,824 (New Position) |
Filing History |